医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

NEWS > Home > > 疾病 > AIDS >

Yes! We Can End TB & AIDS, Says AHF

2024年03月22日 PM04:01
このエントリーをはてなブックマークに追加


 

LOS ANGELES

Join AIDS Healthcare Foundation (AHF) this World Tuberculosis (TB) Day, recognized annually on March 24, to raise awareness of one of the world’s deadliest infectious diseases, which is the leading cause of death for people living with HIV, yet 100% preventable and treatable. AHF country teams will hold World TB Day ‘Yes! We Can End TB & AIDS’ commemorations to honor the millions of lives lost to TB while urging leaders at all levels of government to prioritize TB prevention, testing, and treatment efforts.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240322482439/en/

AIDS Healthcare Foundation (AHF) country teams, which have prioritized screening for TB in clinics—along with preventing and treating HIV/TB co-infection—will hold World TB Day commemorations around the globe. (Graphic: Business Wire)

AIDS Healthcare Foundation (AHF) country teams, which have prioritized screening for TB in clinics—along with preventing and treating HIV/TB co-infection—will hold World TB Day commemorations around the globe. (Graphic: Business Wire)

“World TB Day serves as a crucial reminder of the global health challenge posed by tuberculosis and emphasizes the need for heightened awareness globally. It’s imperative we dispel the myths around TB, reduce stigma, and encourage education to allow for early detection and treatment,” said Guillermina Alaniz, Director of Global Advocacy at AHF. “We urge governments everywhere to make TB a top priority, particularly in low- and middle-income countries where TB is more prevalent, which is vital for people living with HIV, as they are more susceptible to TB co-infection. Integrating TB prevention and care into HIV programs, which AHF has done, is essential for comprehensive healthcare. Together, ‘Yes! We Can End TB & AIDS.’”

According to the World Health Organization, TB claimed 1.3 million lives in 2022, including 167,000 people living with HIV, with an estimated nearly 11 million people falling ill to TB worldwide. Multidrug-resistant TB (MDR-TB) remains a public health crisis and a health security threat, yet only about two out of five people with MDR-TB accessed treatment in 2022. Global efforts to combat TB have saved an estimated 75 million lives since 2000.

Visit WeCanEndTB.org to learn more.

AIDS Healthcare Foundation (AHF) is a global non-profit organization providing cutting-edge medicine and advocacy to over 1.9 million people in 46 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region, and Europe. We are currently the largest non-profit provider of HIV/AIDS medical care in the world. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240322482439/en/

CONTACT

US MEDIA CONTACT:

Ged Kenslea, Senior Director, Communications, AHF

+1 323.308.1833 work

+1.323.791.5526 mobile

gedk@aidshealth.org

Denys Nazarov, Director of Global Policy and

Communications, AHF

+1 323.308.1829

denys.nazarov@aidshealth.org

TimeLine: , ,

同じカテゴリーの記事 

  • 卫材启用Medidata Clinical Data Studio推进临床试验效率和患者体验的革新
  • Fujirebio推出研究专用全自动Lumipulse®G GFAP检测试剂盒并进一步强化该公司的神经病学产品阵容
  • Fujirebio Launches the Fully Automated Lumipulse® G GFAP Assay for Research Use Only and Further Strengthens its Neuro Test Menu
  • Pearl、歯科AIで史上最大5,800万ドルの資金調達ラウンドを実施
  • FIGS Announces Date of Second Quarter 2024 Earnings Release, Conference Call and Webcast